Skip to main content

Leading startups benefit from

| News

Leading startups benefit from


The top 100 startups of Switzerland have been revealed. In Venturelab’s Top 100, the Basel region performs particularly well in the biotech sector, while almost all the Basel companies named have benefited directly or indirectly from

time for startup (img: Tashatuvango/shutterstock)

Seven companies from the canton of Basel-Stadt and two from the canton of Basel-Landschaft qualified for the Top 100 of Swiss startups. Now, Venturelab has published its latest ranking. Five biotech startups made it into the top 20 – and two of them are from Basel.

Polyneuron Pharmaceuticals AG (14th place) received support from the healthcare accelerator BaseLaunch, which is operated by The location promotion organization also directly provided services to Cellestia Biotech AG (19th place). With T3 Pharmaceuticals (24th place) and Anaveon AG (37th place) from Bottmingen BL, two other Basel companies supported by BaseLaunch made it into the top 40.

In this year’s top 40 Swiss startups are MaxWell Biosystems (33rd place) and Artidis (36th place). Alongside medtech company Resistell (34th place) from Muttenz BL, they too benefited from The same goes for the micro- and nanotechnology company Qnami (64th place) from Basel. Internet and mobile company MyCamper (87th place) rounds off the Basel region’s companies in the top 100.

The list is topped by four companies in the electronics/mechanics and medtech sectors. In first place is Lausanne drone provider Flyability, followed by medtech company Lunaphore, which also hails from Lausanne. Two German-Swiss companies are in places 3 and 4 – the Zurich medtech company Ava and flight devices provider Wingtra from Zug. The best biotech company in the ranking is Cutiss AG from Zurich in 6th place.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.